The nurse should say that the neostigmine will block the actions of the cholinesterase
Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness of skeletal muscles, exacerbated by periods of activity and ameliorated by periods of rest. These muscles are involved in functions related to breathing and movement of body parts such as arms and legs. In myasthenia gravis, the immune system produces antibodies that block or destroy many of the muscle's receptor sites for a neurotransmitter called acetylcholine. With fewer receptor sites available, fewer nerve signals are received by the muscle, leading to muscle weakness.
Learn more about the Myasthenia gravis in
https://brainly.com/question/29519094
#SPJ4
ntify the diseases that are at an increased risk of transmission due to needle-sharing activities of intravenous drug users.multiple select question.hepatitisaidsasthmaeczema
Hepatitis B and C, and HIV (acquired immune deficiency syndrome) are the diseases that are at an increased risk of transmission due to needle-sharing activities of intravenous drug users.
Chronic liver illness, liver cancer, and even death can result from the viral diseases hepatitis B and C, which predominantly affect the liver.
HIV, the virus that causes AIDS, affects the immune system and hinders the body's ability to fight against infections and some malignancies.
The sharing of needles by intravenous drug users does not spread asthma or eczema.
Sharing needles among intravenous drug users can result in the transfer of other infectious illnesses, in addition to Hepatitis B, Hepatitis C, and HIV.
Sharing needles can raise your chance of developing bacterial infections including septicemia and endocarditis, which is an inflammation of the heart's inner lining (blood poisoning).
To know more about hepatitis, click here,
brainly.com/question/20980613
#SPJ4
the nurse administers carbidopa-levodopa to a client with parkinson's disease. which activity describes the mechanism of action of this medication?
Carbidopa has no therapeutic effect on its own.
Carbidopa has little therapeutic impact on its own; instead, it is utilised to boost the benefits of levodopa. When carbidopa is combined with levodopa, more levodopa is available for usage in the brain to alleviate symptoms.
Carbidopa/levodopa is a combination of the two drugs carbidopa and levodopa. It is also known as levocarb and co-careldopa. It is primarily used to control the symptoms of Parkinson's disease, but it does not delay or prevent the illness from progressing. It is administered orally. The combination of carbidopa and levodopa is used to treat Parkinson's disease, often known as shaking palsy or paralysis agitans. Parkinson's disease is a central nervous system condition (brain and spinal cord).
To learn more about Carbidopa-levodopa, here
https://brainly.com/question/29900412
#SPJ4